Diazoxide is the first-line treatment of CHI and it binds directly to the SUR-1 subunit to open the potassium channel of the pancreatic beta cell, thus inhibiting insulin secretion. The gene discussed is ABCC8; the disease is congenital isolated hyperinsulinism.